ATE89738T1 - Antientzuendungsmittel. - Google Patents

Antientzuendungsmittel.

Info

Publication number
ATE89738T1
ATE89738T1 AT89900524T AT89900524T ATE89738T1 AT E89738 T1 ATE89738 T1 AT E89738T1 AT 89900524 T AT89900524 T AT 89900524T AT 89900524 T AT89900524 T AT 89900524T AT E89738 T1 ATE89738 T1 AT E89738T1
Authority
AT
Austria
Prior art keywords
inflammatory
phospholipase
body tissue
potent anti
inhibiting properties
Prior art date
Application number
AT89900524T
Other languages
English (en)
Inventor
Anil B Mukherjee
Lucio Alberto Miele
Original Assignee
Us Health
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Health filed Critical Us Health
Application granted granted Critical
Publication of ATE89738T1 publication Critical patent/ATE89738T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/005—Enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Mechanical Treatment Of Semiconductor (AREA)
  • Apparatus For Radiation Diagnosis (AREA)
  • Resistance Heating (AREA)
AT89900524T 1987-11-19 1988-11-21 Antientzuendungsmittel. ATE89738T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US07/122,379 US5266562A (en) 1987-11-19 1987-11-19 Anti-inflammatory agents
PCT/US1988/004158 WO1989005147A1 (en) 1987-11-19 1988-11-21 New anti-inflammatory agents
EP89900524A EP0397679B1 (de) 1987-11-19 1988-11-21 Antientzündungsmittel

Publications (1)

Publication Number Publication Date
ATE89738T1 true ATE89738T1 (de) 1993-06-15

Family

ID=22402359

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89900524T ATE89738T1 (de) 1987-11-19 1988-11-21 Antientzuendungsmittel.

Country Status (7)

Country Link
US (1) US5266562A (de)
EP (1) EP0397679B1 (de)
JP (1) JPH03502197A (de)
AT (1) ATE89738T1 (de)
AU (2) AU2812789A (de)
DE (1) DE3881405T2 (de)
WO (1) WO1989005147A1 (de)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01199995A (ja) * 1988-02-04 1989-08-11 Kyowa Hakko Kogyo Co Ltd ホスホリパーゼａ↓２阻害ペプチド
US5561220A (en) * 1991-02-08 1996-10-01 Diatech, Inc. Technetium-99m labeled peptides for imaging inflammation
US6019958A (en) * 1991-02-08 2000-02-01 Diatide, Inc. Technetium-99m labeled peptides for imaging inflammation
US5552525A (en) * 1991-02-08 1996-09-03 Diatech Inc. Technetium-99m labeled peptides for imaging inflammation
US5656602A (en) * 1991-07-04 1997-08-12 Garvan Institute Of Medical Research PLA2 inhibitory compounds
AU6156294A (en) * 1993-03-03 1994-09-26 Teijin Limited Physiologically active peptide
BE1006919A3 (nl) * 1993-03-15 1995-01-24 Ley Marc Jozef Philemon De Farmaceutisch preparaat op basis van clara celeiwit cc10, en het gebruik daarvan als geneesmiddel en diagnosticum.
US6288039B1 (en) 1995-03-07 2001-09-11 George Washington University Pharmaceutical compositions methods and kits for treatment and diagnosis of breast cancer
US5696092A (en) * 1995-03-07 1997-12-09 George Washington University Methods and compositions for inhibiting metastasis of epithelial cell-derived cancers
US6509316B2 (en) 1995-03-07 2003-01-21 George Washington University Pharmaceutical compositions, methods, and kits for treatment and diagnosis of lung cancer
US6358915B1 (en) * 1995-03-07 2002-03-19 George Washington University Methods for inhibiting metastasis
US5935860A (en) * 1995-03-07 1999-08-10 The George Washington University Use of uteroglobin expression as a molecular marker for prostatic intraepithelial neoplasia
US5904144A (en) * 1996-03-22 1999-05-18 Cytotherapeutics, Inc. Method for treating ophthalmic diseases
US6299895B1 (en) 1997-03-24 2001-10-09 Neurotech S.A. Device and method for treating ophthalmic diseases
US6221672B1 (en) 1996-04-30 2001-04-24 Medtronic, Inc. Method for determining platelet inhibitor response
GB9613705D0 (en) * 1996-06-29 1996-08-28 Mini Agriculture & Fisheries Novel peptides
US20030207795A1 (en) * 1997-05-28 2003-11-06 Pilon Aprile L. Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions
US20060281681A1 (en) * 1997-05-28 2006-12-14 Pilon Aprile L Methods and compositions for the reduction of neutrophil influx and for the treatment of bronchpulmonary dysplasia, respiratory distress syndrome, chronic lung disease, pulmonary fibrosis, asthma and chronic obstructive pulmonary disease
US20040047857A1 (en) * 1997-05-28 2004-03-11 Pilon Aprile L. Methods and compositions for the treatment of fibrotic conditions & impaired lung function & to enhance lymphocyte production
US20060025348A1 (en) * 1997-05-28 2006-02-02 Pilon Aprile L Methods and compositions for the treatment of fibrotic conditions & impaired lung function & to enhance lymphocyte production
AU2002300876B2 (en) * 1997-05-28 2006-07-13 Claragen Inc. Use of Recombinant Human Uteroglobin in Treatment of Inflammatory and Fibrotic Conditions
US6255281B1 (en) * 1997-05-28 2001-07-03 Claragen, Inc. And U.S. Government Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions
US7122344B2 (en) * 1997-05-28 2006-10-17 Claragen, Inc. Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions
WO2000072868A2 (en) * 1999-06-01 2000-12-07 Prendergast Patrick T Peptides for therapeutic use
US20030129186A1 (en) 2001-07-25 2003-07-10 Biomarin Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
EP1558264A4 (de) * 2002-09-29 2009-06-17 Surmodics Inc Verfahren für die subretinale verabreichung von therapeutika, einschliesslich steroide; verfahren zur lokalisierung der pharmakodynamischen wirkung an choroid und retina; und relevante verfahren zur behandlung und/oder prävention von retina-erkrankungen
US20060110428A1 (en) 2004-07-02 2006-05-25 Eugene Dejuan Methods and devices for the treatment of ocular conditions
US8003124B2 (en) * 2005-04-08 2011-08-23 Surmodics, Inc. Sustained release implants and methods for subretinal delivery of bioactive agents to treat or prevent retinal disease
SI1889198T1 (sl) 2005-04-28 2015-02-27 Proteus Digital Health, Inc. Farma-informacijski sistem
EP2063905B1 (de) 2006-09-18 2014-07-30 Raptor Pharmaceutical Inc Behandlungen von lebererkrankungen durch verabreichung von konjugaten aus rezeptor-assoziierten proteinen
WO2008084063A1 (en) * 2007-01-09 2008-07-17 Fovea Pharmaceuticals Apparatus for intra-ocular injection
KR20100056507A (ko) * 2007-09-11 2010-05-27 몬도바이오테크 래보래토리즈 아게 치료제로서의 펩티드 ｐｒｏ－ｇｌｙ－ｔｈｒ－ｃｙｓ－ｇｌｕ－ｉｌｅ－ｃｙｓ－ａｌａ－ｔｙｒ－ａｌａ－ａｌａ－ｃｙｓ－ｔｈｒ－ｇｌｙ－ｃｙｓ의 용도
EP2205265A1 (de) * 2007-09-11 2010-07-14 Mondobiotech Laboratories AG Verwendung des peptids thymosin beta 4 allein oder in kombination mit cecropin als therapeutisches mittel
RU2010114034A (ru) * 2007-09-11 2011-10-20 Мондобайотек Лабораториз Аг (Li) Терапевтическое применение нейропептида ei и acth 7-38 и их комбинаций
NZ588895A (en) 2008-05-13 2012-07-27 Clarassance Inc Recombinant human CC10 (rhCC10 aka uteroglobin) and compositions thereof for use in the treatment of nasal rhinitis
DK2398500T3 (da) 2009-02-20 2019-05-13 2 Bbb Medicines B V Glutathion-baseret lægemiddelafgivelsessystem
ES2942923T3 (es) 2009-05-06 2023-06-07 Laboratory Skin Care Inc Composiciones de administración dérmica que comprenden complejos de agente activo-partículas de fosfato de calcio y métodos de uso de las mismas
JP2013507373A (ja) * 2009-10-08 2013-03-04 ニューロテック ユーエスエー， インコーポレイテッド 被包された細胞ベースの送達系におけるｐｅｄｆの使用
KR101597391B1 (ko) 2009-10-15 2016-02-24 클라라산스, 인크. 인플루엔자 치료용 재조합 사람 ｃｃ10 단백질
US9168285B2 (en) 2009-10-15 2015-10-27 Therabron Therapeutics, Inc. Recombinant human CC10 protein for treatment of influenza and ebola
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
WO2016133560A1 (en) * 2015-02-16 2016-08-25 Therabron Therapeutics, Inc. Recombinant human cc10 protein for treatment of influenza and ebola

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4810777A (en) * 1987-03-04 1989-03-07 The United States Of America As Represented By The Department Of Health And Human Services Antimicrobial compounds
DE3850107T2 (de) * 1987-03-04 1995-02-23 The United States Of America, Represented By The Secretary, U.S. Department Of Commerce, Springfield, Va. Neue synthetische bioaktive verbindungen und verfahren zur herstellung bioaktiver wirkungen.

Also Published As

Publication number Publication date
US5266562A (en) 1993-11-30
DE3881405D1 (de) 1993-07-01
EP0397679A4 (en) 1990-12-12
AU2812789A (en) 1989-07-05
JPH03502197A (ja) 1991-05-23
EP0397679A1 (de) 1990-11-22
WO1989005147A1 (en) 1989-06-15
DE3881405T2 (de) 1993-09-09
EP0397679B1 (de) 1993-05-26
AU623620B2 (en) 1992-05-21

Similar Documents

Publication Publication Date Title
ATE89738T1 (de) Antientzuendungsmittel.
ATE96032T1 (de) Verfahren zur herstellung von aloe-erzeugnissen.
ATE55054T1 (de) Renininhibitoren und verfahren zur anwendung derselben.
FR2631228B1 (fr) Implant intra-oculaire de chambre anterieure
NO893400L (no) Hiv protease inhibitorer egnet for behandling av aids.
IT1224499B (it) Composizioni esaltatrici della permeazione cutanea comprendenti glicerol monooleato
DE69028535D1 (de) Herstellung des vaskulären endothelialen zellwachstumsfaktors
AU4053985A (en) Packing of surgical needle and suture
AU3850189A (en) Phosphonate adducts of olefinic lubricants having enhanced properties
DE59509848D1 (de) Kombinationspräparat zur anwendung bei immunologischen erkrankungen
SG139553A1 (en) 7-substituted-hept-6-enoic and -heptanoic acids and derivatives thereof
GB8706141D0 (en) Treatment of damaged limb
NO171269C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive propenonoksimetere og mellomprodukter
SE8804256L (sv) Homogen kiselnitridsintrad kropp och foerfarande foer tillverkning av densamma
ES2043903T3 (es) Mezcla de una substancia de efecto trombolitico y de una substancia antitrombotica.
DE59709922D1 (de) Pflaster zur transdermalen anwendung von pergolid
DE58905768D1 (de) Verfahren zur herstellung von zur rektalen und vaginalen anwendung geeigneten praeparaten biologisch aktiver peptide.
NO173145C (no) Fremgangsmaate for behandling av voerter
TR22497A (tr) P-ksilel ve metonolidan tereftalik asit dimetilester uezerinden tereftalik asidin ueretilmesine mahsus usul
KR900702227A (ko) 트랜지스터 점화 시스템의 최종 점화 스테이지
AU2473388A (en) Treatment of factor viii inhibitors
FR2618602B1 (fr) Source d'electrons
NO890293D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive dibenzo- og pyridobenzo-azepinon-derivater.
EP0402857A3 (de) Verwendung von 17-beta-Cyclopropylaminoandrosten-Derivaten
UA25478A (uk) Спосіб хірургічhої реіhhервації hиркового алотраhсплаhтату реципієhтhими hервовими джерелами

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee